SCHEMBL6154787

SCHEMBL6154787

COc1cc(NC2CCCN(C(=O)OC(C)(C)C)CC2)ccc1C(N)=O

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.61
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
MAPT P10636 1/20 0.54
MAPK1 P28482 1/20 0.54
HTT P42858 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
GAA P10253 4/20 0.47
KMT2A Q03164 2/20 0.46
NSD2 O96028 1/20 0.46
EPHX1 P07099 1/20 0.45
MEN1 O00255 1/20 0.44
GFER P55789 1/20 0.44
GPR119 Q8TDV5 1/20 0.44
PTPN2 P17706 1/20 0.44
PTPN1 P18031 1/20 0.44
PTPN6 P29350 1/20 0.44
STS P08842 1/20 0.44
PDE4B Q07343 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154127 0.96 ALDH1A1 (0.65) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL18970132 0.83 ALDH1A1 (0.68) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6155117 0.83 ALDH1A1 (0.62) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6155198 0.83 ALDH1A1 (0.60) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6154643 0.83 ALDH1A1 (0.60) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6153459 0.82 ALDH1A1 (0.66) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL6154337 0.82 MAPT (0.52) ALDH1A1MAPTGAANSD2
SCHEMBL17390155 0.82 PDE4B (0.66) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL377565 0.81 ALDH1A1 (0.68) ALDH1A1NPC1RAB9AMAPTMAPK1
SCHEMBL27262060 0.81 ALDH1A1 (0.68) ALDH1A1NPC1RAB9AMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 ALDH1A1 2454/4885NPC1 116/4885RAB9A 568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.